JP2014532407A5 - - Google Patents

Download PDF

Info

Publication number
JP2014532407A5
JP2014532407A5 JP2014538879A JP2014538879A JP2014532407A5 JP 2014532407 A5 JP2014532407 A5 JP 2014532407A5 JP 2014538879 A JP2014538879 A JP 2014538879A JP 2014538879 A JP2014538879 A JP 2014538879A JP 2014532407 A5 JP2014532407 A5 JP 2014532407A5
Authority
JP
Japan
Prior art keywords
cancer
leukemia
lymphoma
seq
braf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014538879A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014532407A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/061501 external-priority patent/WO2013062976A1/en
Publication of JP2014532407A publication Critical patent/JP2014532407A/ja
Publication of JP2014532407A5 publication Critical patent/JP2014532407A5/ja
Pending legal-status Critical Current

Links

JP2014538879A 2011-10-24 2012-10-23 がんにおけるbraf変異を検出する方法 Pending JP2014532407A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161550504P 2011-10-24 2011-10-24
US61/550,504 2011-10-24
PCT/US2012/061501 WO2013062976A1 (en) 2011-10-24 2012-10-23 Methods of detecting braf mutations in cancer

Publications (2)

Publication Number Publication Date
JP2014532407A JP2014532407A (ja) 2014-12-08
JP2014532407A5 true JP2014532407A5 (https=) 2015-12-10

Family

ID=47138195

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014538879A Pending JP2014532407A (ja) 2011-10-24 2012-10-23 がんにおけるbraf変異を検出する方法

Country Status (6)

Country Link
US (1) US20130130264A1 (https=)
EP (1) EP2771486A1 (https=)
JP (1) JP2014532407A (https=)
AU (1) AU2012329042A1 (https=)
CA (1) CA2865037A1 (https=)
WO (1) WO2013062976A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2707508A4 (en) * 2011-05-10 2015-07-29 Brunangelo Falini BIOMARKERS OF TRICHOLEUCOCYTE LEUKEMIA AND METHODS OF USE THEREOF
AU2014336987A1 (en) * 2013-10-19 2016-04-14 Trovagene, Inc. Detecting mutations in disease over time
WO2015058175A2 (en) * 2013-10-19 2015-04-23 Trovagene, Inc. Detecting and monitoring mutations in histiocytosis
WO2016007959A1 (en) * 2014-07-11 2016-01-14 Expression Pathology, Inc. Srm/mrm assay for the serine/threonine-protein kinase b-raf (braf)
CN106755489A (zh) * 2017-01-22 2017-05-31 杭州金溪生物技术有限公司 高灵敏度基因突变检测方法及所用试剂盒

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070020657A1 (en) * 2005-05-20 2007-01-25 Grebe Stefan K Methods for detecting circulating tumor cells
WO2007106534A2 (en) * 2006-03-14 2007-09-20 Harbor-Ucla Research And Education Institute Selective amplification of minority mutations using primer blocking high-affinity oligonucleotides
ES2527653T3 (es) * 2008-10-20 2015-01-28 F. Hoffmann-La Roche Ag Amplificación específica de alelo usando un cebador con un nucleótido modificado
EP2707508A4 (en) * 2011-05-10 2015-07-29 Brunangelo Falini BIOMARKERS OF TRICHOLEUCOCYTE LEUKEMIA AND METHODS OF USE THEREOF

Similar Documents

Publication Publication Date Title
US20220372579A1 (en) METHODS FOR DETECTING CpG METHYLATION AND FOR DIAGNOSING CANCER
JP2014532407A5 (https=)
Lecomte et al. Circulating free tumor DNA and colorectal cancer
US20200340062A1 (en) Prognostic markers for cancer recurrence
FI4026917T3 (fi) Menetelmä ja välineistö solujen tai kudoksen kuoleman tai DNA:n kudos- tai solualkuperäin määrittämiseksi DNA-metylaatioanalyysin avulla
JP2015091235A5 (https=)
CN109777877B (zh) 基于ptbp1甲基化辅助诊断脑动脉瘤的检测试剂盒及其应用
CN107502654A (zh) 用于实体瘤靶向用药指导的多基因富集和检测方法
Yu et al. High-resolution melting analysis of PCDH10 methylation levels in gastric, colorectal and pancreatic cancers
Taenzer et al. Molecular biomarkers in esophageal, gastric, and colorectal adenocarcinoma
CN102796817A (zh) 一种快速检测kras基因突变的方法
WO2006084051A3 (en) Use of id4 for diagnosis and treatment of cancer
CN109072290A (zh) 用于检测基因突变的方法
JP2015500638A5 (https=)
Mahdavinezhad et al. Association between tissue miR-141, miR-200c and miR-30b and bladder cancer: a matched case-control study
Xie et al. Evaluating the clinical feasibility: The direct bisulfite genomic sequencing for examination of methylated status of E3 ubiquitin ligase RNF180 DNA promoter to predict the survival of gastric cancer
CN104087674B (zh) 一种人表皮生长因子受体突变基因检测试剂盒
US20220081722A1 (en) Method of Diagnosing Gastric Cancers Using MicroRNAs
Choi et al. Prognostic impact of polymorphisms in the CASPASE genes on survival of patients with colorectal cancer
Naidu et al. Polymorphism of FGFR4 Gly388Arg does not confer an increased risk to breast cancer development
CN103361404A (zh) 一种检测肝癌相关风险基因的试剂盒
Zidan et al. Prognostic impact of nucleophosmin 1 (NPM1) gene mutations in Egyptian acute myeloid leukemia patients
Vandepoele et al. The YPEL5–PPP1CB fusion transcript is detected in different hematological malignancies and in normal samples
Abd El Hassib et al. The role of miRNA-196a2 genotypes in the susceptibility of acute lymphoblastic leukemia in Egyptian children
DE602004029477D1 (de) Methode zur detektion und beobachtung von krankheiten durch analyse von an den zellen gebundenen nukleinsäuren